They differ from GLP-1s in that they target not only the GLP-1 hormone but also the GIP (glucose-dependent insulinotropic polypeptide) hormone, which helps to lower A1C, or blood glucose levels
Emerging research on the potential benefits of GLP-1swhich include semaglutide (Wegovy and Ozempic) and tirzepatide (Mounjaro and Zepbound)for treating PCOS suggests Nirchi may be far from alone in finding this type of drug life-changing
These combined effects highlight its potential in accelerating tissue repair (11)
Comparing Liraglutide, Semaglutide, and GLP-1 Therapies for Weight Loss at Vive Ageless Weight Loss Center Not all GLP-1 therapies are the same, and understanding the differences is critical
While some individual ingredients, such as berberine, have modest evidence of weight loss when taken orally at therapeutic doses, there is no evidence that meaningful amounts can be delivered through skin patches